Yukito Shinohara. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Cost of IllnessFibrinolytic Agents/therapeutic useHumansJapan/epidemiologySocieties, Medical/organization & administrationStroke/epidemiologyStroke/therapyThrombolytic Therapy
Substances: See more » Fibrinolytic Agents
Year: 2007 PMID: 18705971 DOI: 10.1111/j.1747-4949.2007.00106.x
Source DB: PubMed Journal: Int J Stroke ISSN: 1747-4930 Impact factor: 5.266